top of page
Browse by category
Search


FDA reviewing ProSomnus’ EVO medical device for severe OSA
The FDA has accepted, and is in the process of reviewing, the ProSomnus’ premarket notification for its ProSomnus EVO precision medical...


Obesity Bill of Rights to define quality obesity care as the right of all adults
The National Consumers League (NCL) and National Council on Aging (NCOA) in the US have introduced the nation's first Obesity Bill of...


FDA approves USGI Medical’s pivotal study of the POSE2.0 procedure for primary obesity
The FDA has approved an USGI Medical’s Investigational Device Exemption application to conduct a pivotal study of its POSE2.0...


Journal Watch 31/01/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


How obesity dismantles mitochondria, the key mechanism behind obesity-related metabolic dysfunction
Researchers from University of California San Diego School of Medicine have shed new light on how obesity affects our mitochondria, the...


New way of fasting may protect against inflammation
Researchers at the University of Cambridge have discovered a new way that fasting helps reduce inflammation, a potentially damaging...


Obesity and alcohol are contributing to increases in CRC rates among young adults
Overweight and obesity are contributing to rising death rates from bowel cancer among people aged 25–49 years in the European Union (EU)...


Bariatric surgery can impair midwall left ventricular dysfunction in certain patients one-year after surgery
Patients with severe obesity and in particular women with hypertension, higher level of inflammation and reduced ejection fraction, have...


Perioperative risk should not be a main deciding factor in the choice of procedure
Both sleeve gastrectomy and Roux-en-Y gastric bypass can be performed with a similar and low perioperative risk therefore, the...


Roche enters weight loss and metabolic market with Carmot Therapeutics acquisition
Roche has completed its acquisition of Carmot Therapeutics, which includes Carmot’s R&D portfolio including all clinical and pre-clinical...
Browse by tag






bottom of page

